Clinical Trials Browser

Withdrawn × Colorectal Neoplasms × Clear all

NCT07137390 2026-03-11

A Trial of Regorafenib Plus Lorigerlimab as Neoadjuvant Therapy for Patients With pMMR/MSS, Resectable, Lung-limited Metastatic Colorectal Cancer

Phase 1/2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT03804255 2026-03-02

Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting

BreastDermatologicGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms

NCT05512260 2026-02-11

BESTa

Phase NA Withdrawn

BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT06501989 2026-02-11

Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT07323576 2026-02-09

INAVO-CRC

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT05329870 2026-01-16

Does Genetic Susceptibility for Bleeding Affect Quantitative Faecal Immunochemical Test (qFIT) Results?

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT06626256 2025-12-24

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Phase 1 Withdrawn

DermatologicGastrointestinalGenitourinaryGynecologic

Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms, Colorectal Neoplasms

NCT06557278 2025-10-21

COMUNITY

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT06730100 2025-10-06

CBX-12 for the Treatment of Metastatic Chemotherapy-Refractory Microsatellite Stable Colorectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT06410534 2025-09-11

A Phase II Study Evaluating an Organ Preservation Strategy Using Immune Checkpoint Blockade for Participants With Primary Colorectal or Gastroesophageal Cancer

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT06690281 2025-09-11

A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies

Phase 2 Withdrawn

Gastrointestinal

Duodenal Neoplasms, Liver Neoplasms, Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT06084689 2025-09-02

EMPIRE

Phase 2 Withdrawn

BreastGastrointestinalSarcomaThoracic

Tertiary Lymphoid Structures, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Sarcoma, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT06707896 2025-06-25

TCR1020-CD8 T Cells in KRAS-mutated Cancers

Phase 1 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT04148378 2025-06-05

A Pilot Study to Explore the Role of Gut Flora in Colorectal Cancer

Gastrointestinal

Colorectal Neoplasms

NCT03879811 2025-05-15

Determining the Effects of Temozolomide Followed by Nivolumab in Patients With Colorectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT05940844 2025-04-09

Study of OB-002 in Patients With Refractory Metastatic Cancer

Phase 1 Withdrawn

BreastGastrointestinalGenitourinary

Breast Neoplasms, Carcinoma, Transitional Cell, Neoplasm Metastasis, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT04889495 2025-03-19

A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer

BreastGastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Kidney Neoplasms, Colorectal Neoplasms

NCT04976660 2025-03-18

TT-4 As a Single Agent in Subjects with Advanced Selected Solid Tumors

Phase 1/2 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT05584540 2025-03-12

UNTIRE: Cancer-related Fatigue With Digital Treatment

Phase NA Withdrawn

Gastrointestinal

Fatigue, Colorectal Neoplasms

NCT03169777 2025-02-21

QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC

Phase 1/2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT05158374 2025-02-06

Molecular Effects of Aspirin & Metformin on Colonic Epithelium

Phase NA Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT03802747 2024-12-09

Immunotherapy Combined With Y-90 and SBRT for Colorectal Liver Metastases

Phase 1 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT03228043 2024-11-14

Apatinib for Resectable Colorectal Cancer

Phase NA Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT04192929 2024-11-06

Chromoendoscopy or Narrow Band Imaging (NBI) for Improving Adenoma Detection in Colonoscopy

Phase NA Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT01847495 2024-10-04

Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis

Phase NA Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT04258969 2024-10-01

Pedaling at a Low-Moderate Intensity During Chemotherapy Administration

Phase NA Withdrawn

Gastrointestinal

Motor Activity, Colorectal Neoplasms, Sarcopenia

NCT05518032 2024-09-26

Pembrolizumab and Autologous Dendritic Cells for the Treatment of Refractory Colorectal Cancer (CRC)

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT05356897 2024-09-19

Tucatinib Combined with Trastuzumab and TAS-102 for the Treatment of HER2 Positive Metastatic Colorectal Cancer in Molecularly Selected Patients, 3T Study

Phase 2 Withdrawn

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT06216561 2024-08-20

Intraperitoneal LSTA1 in CRS-HIPEC

Phase 1 Withdrawn

GastrointestinalGynecologic

Appendiceal Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT05690035 2024-07-09

Tislelizumab Combined With Fruquintinib for Metastatic pMMR/MSS Colorectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT05900648 2024-04-29

Regorafenib and XmAb20717 in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy (RX-CROME)

Phase 2 Withdrawn

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT05356585 2024-04-12

Circulating Tumor DNA to Monitor the Efficacy of Total Neoadjuvant Therapy for Rectal Cancer

Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT03733197 2024-03-22

#CuttingCRC: Barbershop-Based Trial & Colorectal Cancer

Phase NA Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT00846313 2023-12-29

ColErn

Phase NA Withdrawn

Gastrointestinal

Colorectal Neoplasms, Weight Loss

NCT04870034 2023-12-22

Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer

Phase EARLY_PHASE1 Withdrawn

GastrointestinalThoracic

Adenocarcinoma of Lung, Pancreatic Neoplasms, Colorectal Neoplasms

NCT04054752 2023-11-02

Vaccine Response With NT-I7

Phase 1 Withdrawn

BreastGastrointestinalGenitourinary

Urinary Bladder Neoplasms, Breast Neoplasms, Colorectal Neoplasms

NCT05821582 2023-10-12

Study SBX-01-101: A Stool Collection Study in Colorectal Cancer (CRC) Patients Treated With Irinotecan-Based Regimens

Gastrointestinal

Colorectal Neoplasms

NCT05092750 2023-09-28

Magnetic Particle-ICG Lymph Node Mapping in Colorectal Cancer

Phase 1/2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT02535988 2023-09-21

Abscopal Effect for Metastatic Colorectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT05412706 2023-09-08

Bohème

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT05951842 2023-07-19

Anesthesia, TIVA, Balanced Anesthesia, NK Cell

Phase NA Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT05582031 2023-06-07

REFIT-MSS

Phase 2 Withdrawn

GastrointestinalOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Anus Neoplasms, Sarcoma, Colorectal Neoplasms, Small Cell Lung Carcinoma

NCT04535492 2023-05-11

Technology-Based Cancer Screening Intervention

Phase NA Withdrawn

BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Colorectal Neoplasms

NCT05246943 2023-04-25

The Correlation of a D-dimer Testing Protocol With Venous Thromboembolism in Surgical Colorectal Patients

Gastrointestinal

Diverticular Diseases, Colitis, Ulcerative, Crohn Disease, Thrombosis, Colorectal Neoplasms, Venous Thrombosis

NCT05183295 2023-04-03

Medical Food for the Dietary Management of Metastatic Colorectal Cancer

Phase NA Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT03742596 2023-03-15

Effect of Probiotics Supplementation on the Side Effects of Radiation Therapy Among Colorectal Cancer Patients

Phase 2/3 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT01792882 2023-02-28

GBCPRT0008

BreastGastrointestinalGenitourinaryOther hematologic neoplasmThoracic

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms

NCT05606081 2023-02-28

PREDICT

Phase NA Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT05730673 2023-02-17

Leronlimab in Combination With Regorafenib in Patients With CCR5+, Metastatic Colorectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT03982173 2023-01-26

MATILDA

Phase 2 Withdrawn

BreastGastrointestinal

Adenocarcinoma Of Esophagus, Colorectal Neoplasms, Triple Negative Breast Neoplasms